Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- NRRIndependent statistical analysis of Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NRRIndependent statistical analysis of Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- NRRIndependent statistical analysis of Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NSAID Effects on Clinical and Imaging Breast Biomarkers: Complete Statistical AnalysisIndependent statistical analysis of NSAID Effects on Clinical and Imaging Breast Biomarkers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01761877).
- NSAID Use in Postpartum Hypertensive Women: Complete Statistical AnalysisIndependent statistical analysis of NSAID Use in Postpartum Hypertensive Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02902172).
- NSCLCIndependent statistical analysis of Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- NSCLCIndependent statistical analysis of Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NSCLCIndependent statistical analysis of Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00673049).
- NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries: Complete Statistical AnalysisIndependent statistical analysis of NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- nSTRIDE APS Versus Hyaluronic Acid for Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of nSTRIDE APS Versus Hyaluronic Acid for Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03182374).
- NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NT-I7 for Kaposi Sarcoma in Patients With or Without HIV: Complete Statistical AnalysisIndependent statistical analysis of NT-I7 for Kaposi Sarcoma in Patients With or Without HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04893018).
- NTRKIndependent statistical analysis of A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- NTXIndependent statistical analysis of Naltrexone for Antipsychotic-Induced Weight Gain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01866098).
- NTXIndependent statistical analysis of Stryker NTX Registry Scorpio NRG (Re-"Energize"), Triathlon Total Knee, Triathlon Partial Knee Resurfacing (PKR) With X3 Polyethylene Insert: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- NTX-PED-001Independent statistical analysis of Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer: Complete Statistical AnalysisIndependent statistical analysis of Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05276401).
- NU-DSMPIndependent statistical analysis of Pilot Trial of the Nutrition-Supported Diabetes Education Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05067452).
- NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours: Complete Statistical AnalysisIndependent statistical analysis of NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- NUCALA® Special Drug Use Investigation (EGPA, Long-term): Complete Statistical AnalysisIndependent statistical analysis of NUCALA® Special Drug Use Investigation (EGPA, Long-term): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03557060).
- NUDGE-EHRIndependent statistical analysis of NUDGE-EHR Replication Trial at Mass General Brigham: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05538065).
- NUDGE-EHRIndependent statistical analysis of Optimizing Electronic Health Record Prompts With Behavioral Economics to Improve Prescribing for Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Nudges and Incentives to Enhance the Opioid Treatment Workforce: Complete Statistical AnalysisIndependent statistical analysis of Nudges and Incentives to Enhance the Opioid Treatment Workforce: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03834025).
- Nudging Provider Adoption of Clinical Decision Support: Complete Statistical AnalysisIndependent statistical analysis of Nudging Provider Adoption of Clinical Decision Support: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05203185).
- NUPRO Sensodyne Prophylaxis Paste With NovaMin Sensitivity Relief Study: Complete Statistical AnalysisIndependent statistical analysis of NUPRO Sensodyne Prophylaxis Paste With NovaMin Sensitivity Relief Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01669785).
- Nurse Coach-Led Early Palliative Care for Older Adults With COPD and Their Care Partners: The Project EPIC Pilot RCT: Complete Statistical AnalysisIndependent statistical analysis of Nurse Coach-Led Early Palliative Care for Older Adults With COPD and Their Care Partners: The Project EPIC Pilot RCT: primary endpoint results, effect estimate with confidence interval, sample-size…
- Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab: Complete Statistical AnalysisIndependent statistical analysis of Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01435265).
- Nurse Initiated Acupressure for Pain Management: Complete Statistical AnalysisIndependent statistical analysis of Nurse Initiated Acupressure for Pain Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04044716).
- Nurse-Led Interprofessional Mental Health Promotion Intervention for Older Home Care Clients: Complete Statistical AnalysisIndependent statistical analysis of Nurse-Led Interprofessional Mental Health Promotion Intervention for Older Home Care Clients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Nurse-led Medicines’ Monitoring in Care Homes: a Process Evaluation: Complete Statistical AnalysisIndependent statistical analysis of Nurse-led Medicines' Monitoring in Care Homes: a Process Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03110471).
- NURTUREIndependent statistical analysis of A Study of Multiple Doses of Nusinersen (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy: primary endpoint results, effect estimate with confidence interval,…
- NURTURE 1Independent statistical analysis of Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis…
- Nutraceutical Efficacy for rUTI: Complete Statistical AnalysisIndependent statistical analysis of Nutraceutical Efficacy for rUTI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03395288).
- Nutricity: An mHealth Nutrition Intervention to Improve Diet Quality Among Latino Children: Complete Statistical AnalysisIndependent statistical analysis of Nutricity: An mHealth Nutrition Intervention to Improve Diet Quality Among Latino Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nutrition Monitoring and Feeding Optimization With the smART+ System – Comparative Study: Complete Statistical AnalysisIndependent statistical analysis of Nutrition Monitoring and Feeding Optimization With the smART+ System - Comparative Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nutritional Education and the Prevention of Iron Depletion in Children 9 Months to 2 Years: Complete Statistical AnalysisIndependent statistical analysis of Nutritional Education and the Prevention of Iron Depletion in Children 9 Months to 2 Years: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NVA237 BID Versus Placebo Twelve-week Efficacy Study: Complete Statistical AnalysisIndependent statistical analysis of NVA237 BID Versus Placebo Twelve-week Efficacy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01715298).
- NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine: Complete Statistical AnalysisIndependent statistical analysis of NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00199849).
- O-BMTIndependent statistical analysis of Onsite Buprenorphine Treatment at Syringe Exchange Programs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03150173).
- OA CAREIndependent statistical analysis of OA Clinic-Community CARE Model: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05349500).
- OA-PCPIndependent statistical analysis of Physical Activity Pathway for Patients With Osteoarthritis in Primary Care (OA-PCP) (R33): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- OAKIndependent statistical analysis of Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- OAKTREEComplete statistical analysis of the randomized phase 3 OAKTREE trial of obeldesivir in nonhospitalized participants with COVID-19, including trial design, endpoints, survival analysis, viral-load analysis, safety, statistical methodology, results, and interpretation.
- OARS-PilotIndependent statistical analysis of Opioid Analgesic Reduction Study (OARS) - Pilot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05283499).
- OARSCMIndependent statistical analysis of Reward-based Technology to Improve OUD Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05180669).
- OASISIndependent statistical analysis of Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04720664).
- OASISIndependent statistical analysis of Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- OASISIndependent statistical analysis of BlueWind RENOVA iStim™ System for the Treatment of OAB: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03596671).
- OASISIndependent statistical analysis of Global Sinus Surgery Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02347943).